Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Innovating Information
Boise, Idaho - The most significant impact of information therapy on a dermatology practice will be extending the doctor's office into the patient's home, said Donald W. Kemper, chief executive officer of Healthwise, Inc., a healthcare decision-making company. Several years ago Kemper coined "information therapy," or "Ix." The term refers to the provision of current, evidence-based information to patients and their caregivers at each step of diagnosis and treatment.
Related Videos
Related Content
